News for Grifols, S.A. (GIKLY)

**media[650332]**

Mason Capital Management supports Grifols' recommended director slate at the upcoming shareholder meeting. Mason holds approximately 3% of Grifols' class A

Grifols, S.A. (NASDAQ:GRFS) Q1 2025 Earnings Conference Call May 12, 2025 12:30 PM ETCompany ParticipantsDanny Segarra - VP, IR and SustainabilityNacho Abia...

The following slide deck was published by Grifols, S.A.

PR NewswireSOUTH SAN FRANCISCO, Calif., May 6, 2025 First quarter 2025 total revenue of approximately $53.3 million, which includes net product sales of $4

White Falcon Capital Management, an investment fund manager, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund’s performance for the recent quarter was below expectations, as the gains from gold and silver royalty holdings were unable to cover the losses in some of the larger positions. On […]

White Falcon Capital Management, an investment fund manager, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.

PR NewswireSOUTH SAN FRANCISCO, Calif., March 4, 2025 Fourth quarter 2024 total revenue of approximately $57.6 million, which includes TAVALISSE® net prod

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Grifols, S.A.

The following slide deck was published by Grifols, S.A.

Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday. Shares of Dell Technologies Inc. DELL fell sharply in t...

U.S. stock futures were lower this morning, with the Dow futures falling more than 250 points on Tuesday. Shares of AECOM ACM fell sharply in today's pre-marke...

Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors

The plasma protein therapeutics market is experiencing notable growth, driven by the essential role these therapies play in treating various conditions...

Infectious Disease Diagnostics Market size was valued at USD 22.94 billion in 2023 to USD 43.09 billion by 2031...

Discover the booming blood screening market from 2024 to 2031, as innovative technologies and rising health awareness drive demand across diverse product...

The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1...

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Tuesday. Shares of Snowflake Inc. SNOW fell in today's pre-mar...